A Microfabrication Platform for Direct Printing Vascularized Functional Tissue Co

$360,540R01FY2012EBNIH

University Of California, San Diego, La Jolla CA

Investigators

Linked publications & trials

Paper 32189815 Paper 30375196 Paper 30319321 Paper 29663706 Paper 29626550 Paper 29542324 Paper 29323433 Paper 29200661 Paper 28852429 Paper 28782184 Paper 28546915 Paper 28498548 Paper 28289247 Paper 28265064 Paper 28211642 Paper 28195834 Paper 28088667 Paper 27856795 Paper 27826004 Paper 27722710 Paper 27648113 Paper 27641724 Paper 27617489 Paper 27525102 Paper 27510763 Paper 27453781 Paper 27254107 Paper 27232181 Paper 27176482 Paper 27134620 Paper 27126775 Paper 27101419 Paper 27098564 Paper 27047733 Paper 27037064 Paper 26999423 Paper 26996755 Paper 26985572 Paper 26975883 Paper 26928456 Paper 26924450 Paper 26915715 Paper 26858399 Paper 26844597 Paper 26799457 Paper 26778695 Paper 26748753 Paper 26694229 Paper 26611830 Paper 26606883 Paper 26551969 Paper 26523134 Paper 26501166 Paper 26489048 Paper 26453156 Paper 26414409 Paper 26327819 Paper 26304467 Paper 26282117 Paper 26256481 Paper 26121113 Paper 26079524 Paper 26065674 Paper 25900329 Paper 25880725 Paper 25816872 Paper 25530795 Paper 25490422 Paper 25411576 Paper 25309744 Paper 25044366 Paper 24988275 Paper 24958085 Paper 24947233 Paper 24927679 Paper 24906345 Paper 24818770 Paper 24805923 Paper 24778793 Paper 24741694 Paper 24620821 Paper 24453182 Paper 24344625 Paper 24319406 Paper 24290137 Paper 24278097 Paper 24257507 Paper 24253194 Paper 24179675 Paper 24170301 Paper 24150602 Paper 24127350 Paper 24076754 Paper 24060419 Paper 24014252 Paper 23996513 Paper 23973391 Paper 23935392 Paper 23853426 Paper 23747008

Abstract

DESCRIPTION (provided by applicant): The long term goal of our research is to design complex biomaterial scaffolds that can mimic the micro- architecture of cardiac tissues and to augment regeneration therapies. These tissue-like structures will have the appropriate microarchitectural features of native tissues including a functioning vasculature. To fabricate these tissues we are interested in using natural molecules such as hyaluronic acid (HA; also called hyaluronan)-based biomaterials, because of the ubiquitous presence of HA in the extracellular matrix (ECM) of tissues and the significant role that HA inherently plays in wound healing. The objective of the proposed research is to develop methods to create 3D scaffolds of native ECM components with complex internal architecture and cell encapsulation. To fabricate such scaffolds, we will develop an innovative direct-write platform based on a projection-style stereolithographic (SL) method, coined as PSL. In Specific Aim 1, we will develop and optimize the PSL system for the fabrication of 3D microstructures using HA with Arg-Gly-Asp (RGD) and matrix metalloproteinase (MMP). In Specific Aim 2, we will use PSL for Direct-write 3D HA scaffolds encapsulating cardiomyocytes. In Specific Aim 3, we will create vascularized structures in a 3D scaffold and analyze vasculature functions. We will seed an endothelial cell lining within microchannels. The seeding process will be optimized by adjusting the cell seeding density and duration as well as surface chemistry. The vascular function and biomechanical properties of these engineered tissue constructs will be determined in vitro. PUBLIC HEALTH RELEVANCE: This project seeks to develop a novel biofabrication platform to create three-dimensional (3D) scaffolds of native extracellular matrix components with complex internal architectures and cell encapsulation. The goal of the project is to create vascularized structures in the 3D scaffolds

View original record on NIH RePORTER →